Trial record 6 of 76 for:    pelvic inflammatory disease AND (woman OR women OR female)

Rate of Pelvic Inflammatory Disease at St. Michael's Hospital

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
St. Michael's Hospital, Toronto
ClinicalTrials.gov Identifier:
NCT00783419
First received: October 30, 2008
Last updated: September 2, 2011
Last verified: October 2008
  Purpose

A retrospective review of women who came through the ER at SMH with a pelvic inflammatory disease (PID) or tubo-ovarian abscess (TOA) between 1995-2005. They were looking at people with this diagnosis to determine how they were treated, whether as inpatient or outpatient and whether they were treated with drugs and how were these given and also did they develop an abscess.


Condition
Pelvic Inflammatory Disease

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Rate of Pelvic Inflammatory Disease and Tubo-ovarian Abscess at SMH

Resource links provided by NLM:


Further study details as provided by St. Michael's Hospital, Toronto:

Estimated Enrollment: 55
Study Start Date: March 2007
Study Completion Date: January 2011
Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)
  Eligibility

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Women with pelvic-inflammatory disease or tubo-ovarian abscess

Criteria

Inclusion Criteria:

  • women admitted to Emergency with pelvic-inflammatory disease or tubo-ovarian abscess from the year range: 1995-2000

Exclusion Criteria:

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00783419

Locations
Canada, Ontario
St. Michael's Hospital
Toronto, Ontario, Canada, M5B1W8
Sponsors and Collaborators
St. Michael's Hospital, Toronto
Investigators
Principal Investigator: Mark Yudin, MD St. Michael's Hospital, Toronto
  More Information

No publications provided

Responsible Party: St. Michael's Hospital, Toronto
ClinicalTrials.gov Identifier: NCT00783419     History of Changes
Other Study ID Numbers: REB 07-042
Study First Received: October 30, 2008
Last Updated: September 2, 2011
Health Authority: Canada: Ethics Review Committee

Keywords provided by St. Michael's Hospital, Toronto:
tubo-ovarian abscess, pelvic-inflammatory disease

Additional relevant MeSH terms:
Pelvic Inflammatory Disease
Pelvic Infection
Infection
Adnexal Diseases
Genital Diseases, Female

ClinicalTrials.gov processed this record on September 11, 2014